Startups

Helex
Develops kidney-targeted genomic medicines and lipid-nanoparticle delivery systems. Its lead program addresses autosomal dominant polycystic kidney disease.
Startups

Develops kidney-targeted genomic medicines and lipid-nanoparticle delivery systems. Its lead program addresses autosomal dominant polycystic kidney disease.